Related Experiment Video
Updated: May 3, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
MT-CYB mutations in hypertrophic cardiomyopathy
Christian M Hagen1, Frederik H Aidt2, Ole Havndrup3
1Department of Clinical Biochemistry, Immunology, and Genetics, Statens Serum Institut Copenhagen, Denmark ; Department of Biomedical Sciences, University of Copenhagen Copenhagen, Denmark.
Insights
Rare mutations in the MT-CYB gene, which codes for cytochrome B in mitochondrial complex III, were found in hypertrophic cardiomyopathy (HCM) patients, suggesting a role in the disease.
Area of Science:
- Genetics
- Cardiology
- Mitochondrial Biology
Background:
- Mitochondrial dysfunction is a hallmark of heart failure.
- Mutations in mitochondrial DNA (mtDNA), specifically MT-CYB (cytochrome B in complex III), are linked to hypertrophic cardiomyopathy (HCM).
Purpose of the Study:
- To investigate the potential causal or modifying role of MT-CYB mutations in HCM.
- To identify and characterize novel MT-CYB variants in Danish HCM probands.
Main Methods:
- Sequencing of the MT-CYB gene in DNA from 91 Danish HCM patients.
- Bioinformatics analysis, molecular modeling, and simulation of identified nonsynonymous variants.
Main Results:
- Two germline-inherited, potentially pathogenic nonsynonymous variants, m.15024G>A (p.C93Y) and m.15482T>C (p.S246P), were identified in MT-CYB.
- Molecular modeling indicated that p.C93Y disrupts cytochrome B's tertiary structure and heme interaction, while p.S246P alters secondary structure and protein backbone, consistent with a leaky mitochondrial dysfunction phenotype.
Conclusions:
- Rare, potentially leaky mtDNA variants in MT-CYB can be found in HCM patients.
- Further investigation of MT-CYB mutations in HCM patients is warranted to elucidate their role in the disease.
Abstract:
Mitochondrial dysfunction is a characteristic of heart failure. Mutations in mitochondrial DNA, particularly in MT-CYB coding for cytochrome B in complex III (CIII), have been associated with isolated hypertrophic cardiomyopathy (HCM). We hypothesized that MT-CYB mutations might play an important causal or modifying role in HCM. The MT-CYB gene was sequenced from DNA isolated from blood from 91 Danish HCM probands. Nonsynonymous variants were analyzed by bioinformatics, molecular modeling and simulation. Two germline-inherited, putative disease-causing, nonsynonymous variants: m.15024G>A; p.C93Y and m.15482T>C; p.S246P were identified. Modeling showed that the p.C93Y mutation leads to disruption of the tertiary structure of Cytb by helix displacement, interfering with protein-heme interaction. The p.S246P mutation induces a diproline structure, which alters local secondary structure and induces a kink in the protein backbone, interfering with macromolecular interactions. These molecular effects are compatible with a leaky phenotype, that is, limited but progressive mitochondrial dysfunction. In conclusion, we find that rare, putative leaky mtDNA variants in MT-CYB can be identified in a cohort of HCM patients. We propose that further patients with HCM should be examined for mutations in MT-CYB in order to clarify the role of these variants.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis I: Introduction

